Announced
Synopsis
Zur Rose Group, a retailer of pharmaceutical products, agreed to acquire the mail-order and diabetes activities of Apotal, a mail-order pharmacy. Financial terms were not disclosed. "Apotal has built a strongly performing OTC online business which we will develop further, capitalizing on our leading position in electronic prescription and ehealth services. Our market and innovation leadership as pre-eminent digital health services provider focusing on the future requirements of the customer health journey is thus strengthened . We are looking forward to working with the management and the entire team of Apotal as part of a stronger Zur Rose Group," Walter Oberhänsli, Zur Rose Group CEO.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.